share_log
Reuters ·  Feb 18 20:45
Maia Biotechnology : To Use Proceeds Received From Private Placement to Fund Starting Cost for Part C of Phase II Trial Thio -101
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 352

Recommended

Write a comment